Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
出版年份 2023 全文链接
标题
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
作者
关键词
-
出版物
Multiple Sclerosis and Related Disorders
Volume 72, Issue -, Pages 104582
出版商
Elsevier BV
发表日期
2023-02-25
DOI
10.1016/j.msard.2023.104582
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
- (2022) Sapir Dreyer-Alster et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
- (2022) Gisella Guerrera et al. Multiple Sclerosis Journal
- Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
- (2022) Naif Khalaf Alharbi et al. Infection and Drug Resistance
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- (2021) Caroline Papeix et al. Multiple Sclerosis Journal
- Risk and outcomes of COVID‐19 in patients with multiple sclerosis
- (2021) Irene Moreno‐Torres et al. EUROPEAN JOURNAL OF NEUROLOGY
- mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
- (2021) Massimiliano Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
- (2021) Maria Pia Sormani et al. EBioMedicine
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
- (2021) Z.L.E. van Kempen et al. Multiple Sclerosis and Related Disorders
- Risk of MS relapse after yellow fever vaccination
- (2020) Angela Huttner et al. Neurology-Neuroimmunology & Neuroinflammation
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
- (2011) Mauricio F. Farez ARCHIVES OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now